Soliton Inc
  • Clinicians
  • Patients
  • RAP
  • Trials
  • Standards
  • About
  • Investors
  • News
  • Sign-Up

Press Releases

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • In The News
    • IR Calendar
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Scientific Advisory Board
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • In The News
  • IR Calendar

Soliton Completes Trial Enrollment and Conducts Initial Site Training to Start Keloid Trial

Sep 17, 2019

Soliton Announces Site Selected for Clinical Trial to Treat Fibrotic Scars

Sep 10, 2019

Soliton Releases Letter to Shareholders

Sep 9, 2019

Soliton Announces IRB Approval for Keloid Trial

Sep 4, 2019

Soliton to Initiate POC Clinical Trials to Treat Fibrotic Scars Using Acoustic Shockwaves; Estimated Market Size of $10 Billion by 2025

Aug 29, 2019

Soliton Engages argodesign in Preparation of Commercial Launch of its RAP Device

Aug 26, 2019

Soliton Announces Positive Results Demonstrated from Longer RAP Treatment

Aug 20, 2019

Dr. Michael Kaminer Presented Soliton RAP for Cellulite at Key Dermatology Conference

Aug 16, 2019

Soliton Treats First Patients in Pivotal Cellulite Trial

Aug 14, 2019

Soliton Announces Patient Recruitment Has Begun for Pivotal Cellulite Trial

Aug 12, 2019
RSS
    • 1...
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12

    To Follow Our Progress, Sign Up Here:

    Additional Information

    • Privacy Policy
    • Contact

    Social Media

    Links

    • About
    • Clinicians
    • Patients
    • Technology
    • Trials
    • Standards

    © 2021 Soliton Inc. All Rights Reserved, Soliton Inc.

      • Clinicians
      • Patients
      • RAP
      • Trials
      • Standards
      • Our Future
      • About
      • Investors